AlphaLife Sciences expands its presence by joining BIO HK 2024, showcasing GenAI-powered solutions for clinical research at this leading biotech event.
Alice Hsu presented AI-powered clinical trials at DIA 2024, while CEO Sharon Chen shared strategic insights on innovative approaches as a panel expert.
AlphaLife Sciences CEO Sharon Chen attended Microsoft Build: AI Day in Bangkok, engaging with CEOs and Satya Nadella on advancing AI and cloud technology.
In the generative AI surge, global pharma explores AI for innovation. Join Sharon Chen and Bogong Zhu at CMAC to discuss AI's impact on clinical research.